Who Pays My Doctor?

Healthcare provider profile · identity verified

Usman Latif, M.D.

Allopathic & Osteopathic Physicians|Anesthesiology|Pain Medicine · KANSAS CITY, KS · NPI 1750443313

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Usman Latif, M.D. received $223,551.96 in general payments during 2025 across 254 reported records.

Globus Medical, Inc. accounted for 25.1% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 12 associated products.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$223,551.96

254 reported records · 8 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported companyCanonical companyAmountShareRecordsYear
Globus Medical, Inc. Unresolved — no canonical attribution shown $56,122.7625.1%612025
SPR Therapeutics, Inc Unresolved — no canonical attribution shown $55,689.3624.9%552025
Nalu Medical, Inc. Unresolved — no canonical attribution shown $46,835.2320.9%562025
Spinal Simplicity, LLC Unresolved — no canonical attribution shown $38,902.7117.4%492025
Saluda Medical Americas, Inc. Unresolved — no canonical attribution shown $24,714.8811.1%272025
Abbott Laboratories Unresolved — no canonical attribution shown $1,181.930.5%42025
Boston Scientific Corporation Unresolved — no canonical attribution shown $59.310.0%12025
VERTEX PHARMACEUTICALS INCORPORATED Unresolved — no canonical attribution shown $45.780.0%12025

What were the payments for?

Payment categories

CategoryAmountRecords
Consulting Fee$141,863.50115
Travel and Lodging$39,790.7256
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program$33,475.0011
Food and Beverage$5,172.7471
Compensation for serving as faculty or as a speaker for a medical education program$3,250.001

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported productTypeReported companyRelated amount*RecordsYear
Senza
Normalized: senza		 Device Globus Medical, Inc. $56,037.26 59 2025
Source payment records
SPRINT PNS System
Normalized: sprint pns system		 Device SPR Therapeutics, Inc $55,689.36 55 2025
Source payment records
Nalu Neurostimulation System
Normalized: nalu neurostimulation system		 Device Nalu Medical, Inc. $46,835.23 56 2025
Source payment records
Evoke
Normalized: evoke		 Device Saluda Medical Americas, Inc. $24,714.88 27 2025
Source payment records
LIBERTY SI
Normalized: liberty si		 Device Spinal Simplicity, LLC $21,285.00 25 2025
Source payment records
PATRIOT SI
Normalized: patriot si		 Device Spinal Simplicity, LLC $10,587.50 4 2025
Source payment records
HA MINUTEMAN G3-R
Normalized: ha minuteman g3 r		 Device Spinal Simplicity, LLC $9,092.71 15 2025
Source payment records
PROCLAIM
Normalized: proclaim		 Device Abbott Laboratories $1,021.83 2 2025
Source payment records
ETERNA
Normalized: eterna		 Device Abbott Laboratories $160.10 2 2025
Source payment records
WaveWriter Alpha Prime 16
Normalized: wavewriter alpha prime 16		 Device Boston Scientific Corporation $59.31 1 2025
Source payment records
Vyrsa V1
Normalized: vyrsa v1		 Device Globus Medical, Inc. $53.52 1 2025
Source payment records
AFFIRM
Normalized: affirm		 Device Globus Medical, Inc. $31.98 1 2025
Source payment records

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

BrandGenericClaimsBeneficiaries
Tizanidine HclTizanidine Hcl617200
GabapentinGabapentin26184
PregabalinPregabalin17453
MethocarbamolMethocarbamol15052
Nortriptyline HclNortriptyline Hcl5820
Cyclobenzaprine HclCyclobenzaprine Hcl5420
LidocaineLidocaine45suppressed
MeloxicamMeloxicam3919
Duloxetine HclDuloxetine Hcl3715
CephalexinCephalexin3131
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen2422
CelecoxibCelecoxib18suppressed
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen18suppressed
IbuprofenIbuprofen16suppressed
DiazepamDiazepam12suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

YearGeneral PaymentsMain payerExplicit productsCompany overlapsPart D coverage
2025 $223,551.96 · 254 records Globus Medical, Inc. AFFIRM, ETERNA, Evoke, HA MINUTEMAN G3-R, LIBERTY SI, Nalu Neurostimulation System, PATRIOT SI, PROCLAIM, SPRINT PNS System, Senza, Vyrsa V1, WaveWriter Alpha Prime 16 — —
2024 — — — — Complete

Questions to ask

Questions you could discuss with your doctor

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Loaded source releases

DatasetYearPublicationSource
CMS Open Payments — General Payments 2025 2026-06-30 Original source
Medicare Part D Prescribers by Provider and Drug 2024 2026-05-06 Original source
NPPES Data Dissemination V2 current / reference data 2026-08-10 Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error